Figure 5. MSC behavior after converged printing process. Cell viability (t = 14 d) in converged printing (CP) approach was comparable to cast control sample for all voltages used A). Chondrogenic differentiation was not compromised by the converged printing (CP) approach, showing no statistical differences in GAG/DNA compared with cast samples, for 5, 10, and 15 kV B). Safranin-O and collagen type II staining shows good proteoglycan and collagen type II distribution throughout the entire construct C). Scale bar = 100 μm, * = p < 0.05.